New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study: Breast cancer disparity equally impacted by social determinants of health, tumor biology

Study: Breast cancer disparity equally impacted by social determinants of health, tumor biology

by University of Illinois at ChicagoCredit: Unsplash/CC0 Public DomainResearchers at the University of Illinois Chicago have examined national data about women with early-stage, estrogen receptor
Oncology February 01,2024
Study: Breast cancer disparity equally impacted by social determinants of health, tumor biology

Study: Breast cancer disparity equally impacted by social determinants of health, tumor biology

by University of Illinois at ChicagoCredit: Unsplash/CC0 Public DomainResearchers at the University of Illinois Chicago have examined national data about women with early-stage, estrogen receptor
Oncology February 01,2024
Researchers identify hallmarks to improving pancreatic cancer therapy

Researchers identify hallmarks to improving pancreatic cancer therapy

by University of California, IrvineInitiation and progression of pancreatic cancer. Pancreatic ductal adenocarcinoma (PDAC) forms from the exocrine tissue of the pancreas. Acinar and ductal cells
Oncology February 01,2024
Researchers identify hallmarks to improving pancreatic cancer therapy

Researchers identify hallmarks to improving pancreatic cancer therapy

by University of California, IrvineInitiation and progression of pancreatic cancer. Pancreatic ductal adenocarcinoma (PDAC) forms from the exocrine tissue of the pancreas. Acinar and ductal cells
Oncology February 01,2024
Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

by Ludwig Institute for Cancer ResearchGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.006A Ludwig Cancer Research study has discovered that the presence of
Oncology February 01,2024
Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

by Ludwig Institute for Cancer ResearchGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.006A Ludwig Cancer Research study has discovered that the presence of
Oncology February 01,2024
Study outlines need for measures that improve information and autonomy for cancer patients

Study outlines need for measures that improve information and autonomy for cancer patients

by University of BergenStudy design. This paper is about sub-study 4. Credit:Lung Cancer(2023). DOI: 10.1016/j.lungcan.2023.107312A new study shows that patients can experience reduce
Oncology February 01,2024
Study outlines need for measures that improve information and autonomy for cancer patients

Study outlines need for measures that improve information and autonomy for cancer patients

by University of BergenStudy design. This paper is about sub-study 4. Credit:Lung Cancer(2023). DOI: 10.1016/j.lungcan.2023.107312A new study shows that patients can experience reduce
Oncology February 01,2024
New ovarian cancer screening technique shows reduced false negatives compared to CA125 method

New ovarian cancer screening technique shows reduced false negatives compared to CA125 method

by Justin Jackson , Medical XpressGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101061Researchers at the Department of Obstetrics and Gynecology, Peking
Oncology February 01,2024
New ovarian cancer screening technique shows reduced false negatives compared to CA125 method

New ovarian cancer screening technique shows reduced false negatives compared to CA125 method

by Justin Jackson , Medical XpressGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101061Researchers at the Department of Obstetrics and Gynecology, Peking
Oncology February 01,2024
Researchers identify a potential new target for head and neck cancer immunotherapy

Researchers identify a potential new target for head and neck cancer immunotherapy

by University of California - San DiegoCorrelation between TERT and T/B cell infiltrate varies across solid cancers and predicts survival. (A) Spearman correlation between TERT mRNA expression an
Oncology February 01,2024
Researchers identify a potential new target for head and neck cancer immunotherapy

Researchers identify a potential new target for head and neck cancer immunotherapy

by University of California - San DiegoCorrelation between TERT and T/B cell infiltrate varies across solid cancers and predicts survival. (A) Spearman correlation between TERT mRNA expression an
Oncology February 01,2024
Vitamin A may reduce pancreatitis risk during ALL treatment

Vitamin A may reduce pancreatitis risk during ALL treatment

by Cincinnati Children's Hospital Medical CenterStudy inScience Translational Medicineshows potential benefit of vitamin A treatment to reduce side effect risks during treatment f
Oncology February 01,2024
Vitamin A may reduce pancreatitis risk during ALL treatment

Vitamin A may reduce pancreatitis risk during ALL treatment

by Cincinnati Children's Hospital Medical CenterStudy inScience Translational Medicineshows potential benefit of vitamin A treatment to reduce side effect risks during treatment f
Oncology February 01,2024
Previous cancer treatment not tied to higher stillbirth rate

Previous cancer treatment not tied to higher stillbirth rate

Cancer diagnosis and treatment for adolescent girls and young adult women does not appear to increase the risk of a stillbirth with a later pregnancy, according to a study published Aug. 27 in the&nbs
Oncology February 01,2024
Previous cancer treatment not tied to higher stillbirth rate

Previous cancer treatment not tied to higher stillbirth rate

Cancer diagnosis and treatment for adolescent girls and young adult women does not appear to increase the risk of a stillbirth with a later pregnancy, according to a study published Aug. 27 in the&nbs
Oncology February 01,2024
A promising discovery in the fight against incurable cancers

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal
Oncology February 01,2024
A promising discovery in the fight against incurable cancers

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal
Oncology February 01,2024
Moving the needle on monitoring skin cancer

Moving the needle on monitoring skin cancer

by Benjamin Boettner,Harvard UniversityThe team engineered a strategy for monitoring the immunological responses to a newly devised, locally applied immunotherapy against melanoma. The therapy a
Oncology February 01,2024
Moving the needle on monitoring skin cancer

Moving the needle on monitoring skin cancer

by Benjamin Boettner,Harvard UniversityThe team engineered a strategy for monitoring the immunological responses to a newly devised, locally applied immunotherapy against melanoma. The therapy a
Oncology February 01,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com